Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 131-138

  Horellou, Philippe ^a   Sabaté, Olivier ^a   Buc Caron, Marie Hélène ^a   Mallet, Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE TRANSFER; IMMUNE RESPONSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031106006     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6399     Document Type: Article

References (68)

1. 1. Akli, S., C. Caillaud, E. Vigne, L. D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn, and M. Peschanski. 1993. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3: 224-228.
2. 2. Anton, R., J. H. Kordower, N. T. Maidment, J. S. Manaster, D. J. Kane, S. Rabizadeh, S. B. Schueller, J. Yang, S. Rabizadeh, R. H. Edwards, C. H. Markham, and D. E. Bredesen. 1994. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp. Neurol. 127: 207-218.
3. 3. Badie, B., K. Hunt, J. S. Economou, and K. L. Black. 1994. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35: 910-916.
4. 4. Bajocchi, G., S. H. Feldman, R. G. Crystal, and A. Mastrangeli. 1993. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3: 229-234.
5. 5. Björklund, A., and U. Stenevi. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177: 555-560.
6. 6. Bloom, D. C., N. T. Maidment, A. Tan, V. B. Dissette, L. T. Feldman, and J. G. Stevens. 1995. Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Mol. Brain Res. 31: 48-60.
7. 7. Braithwaite, A. W. 1986. Semipermissive replication of adenovirus 5 in rat brain cells and evidence for an induction of cellular DNA replication in vivo. J. Gen. Virol. 67: 391-396.
8. 8. Brundin, P., R. E. Strecker, O. Lindvall, O. Isacson, O. G. Nilsson, G. Barbin, A. Prochiantz, C. Forni, A. Nieoullon, H. Widner, F. H. Gage, and A. Björklund. 1987. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with parkinson's disease. Ann. N.Y. Acad. Sci. 495: 473-496.
9. 9. Buc-Caron, M.-H. 1995. Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol. Dis. 2: 37-47.
10. 10. Byrnes, A. P., R. E. MacLaren, and H. M. Charlton. 1996. Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16: 3045-3055.
11. 11. Byrnes, A. P., J. E. Rusby, M. J. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66: 1015-1024.
12. 12. Chen, S. H., H. D. Shine, J. C. Goodman, R. G. Grossman, and S. L. Woo. 1994. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91: 3054-3057.
13. 13. Colak, A., J. C. Goodman, S. H. Chen, S. L. Woo, R. G. Grossman, and H. D. Shine. 1995. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum. Gene Ther. 6: 1317-1322.
14. 14. Cunningham, L. A., J. T. Hansen, M. P. Short, and M. C. Bohn. 1991. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561: 192-202.
15. 15. Davidson, B. L., E. D. Allen, K. F. Kozarsky J. M. Wilson, and B. J. Roessler. 1993. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3: 219-223.
16. 16. During, M. J., J. R. Naegele, K. L. O'Malley, and A. I. Geller. 1994. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1403.
17. 17. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91: 6196-6200.
18. 18. Fink, D. J., L. R. Sternberg, P. C. Weber, M. Mata, W. F. Goins, and J. C. Glorioso. 1992. In vivo expression of β-galactosidase in hippocampual neurons by HSV-mediated gene transfer. Hum. Gene Ther. 3: 12-19.
19. 19. Fisher, K. J., H. Choi, J. Burda, S. J. Chen, and J. M. Wilson. 1996. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217: 11-22.
20. 20. Fisher, L. J., H. A. Jinnah, L. C. Kale, G. A. Higgins, and F. H. Gage. 1991. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron 6: 371-380.
21. 21. Goldman, M. J., L. A. Litzky, J. F. Engelhardt, and J. M. Wilson. 1995. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2A-defective recombinant adenoviruses: A preclinical toxicology study. Hum. Gene Ther. 6: 839-851.
22. 22. Goldman, M. J., and J. M. Wilson. 1995. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69: 5951-5958.
23. 23. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36: 59-72.
24. 24. Horellou, P., P. Brundin, P. Kalén, J. Mallet, and A. Björklund. 1990. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5: 393-402.
25. 25. Horellou, P., B. Guibert, V. Leviel, and J. Mallet. 1989. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: Regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl. Acad. Sci. USA 86: 7233-7237.
26. 26. Horellou, P., E. Vigne, M. N. Castel, P. Barnéoud, P. Colin, M. Perricaudet, P. Delaère, and J. Mallet. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport 6: 49-53.
27. 27. Horellou, P., L. Marlier, A. Privat, and J. Mallet. 1990. Behavioural effect of engineered cells that synthesize L-DOPA or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2: 116-119.
28. 28. Huang, S., R. I. Endo, and G. R. Nemerow. 1995. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69: 2257-2263.
29. 29. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8: 148-154.
30. 30. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988-990.
31. 31. Levallois, C., A. Privat, and J. Mallet. 1994. Adenovirus insertion encoding the Lac Z gene in human nervous cells in primary dissociated cultures. C.R. Acad. Sci. Paris, Life Sci. 317: 495-498.
32. 32. Lindvall, O., G. Sawle, H. Widner, J. C. Rothwell, A. Bjorklund, D. Brooks, P. Brundin, R. Frackowiak, C. D. Marsden, P. Odin, et al. 1994. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35: 172-180.
33. 33. Lindvall, O., P. Brundin, H. Widner, S. Rehncrona, B. Gustavii, R. Frackowiak, K. L. Leenders, G. Sawle, J. C. Rothwell, C. D. Marsden, and A. Björklund. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577.
34. 34. Lipton, H. L., and M. C. Dal Canto. 1976. Theiler's virus-induced demyelination: Prevention by immunosuppression. Science 192: 62-64.
35. 35. Lundberg, C., P. Horellou, J. Mallet, and A. Bjorklund. 1996. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 139: 39-53.
36. 36. Mallet, J., F. Blanot, C. Boni, S. Dumas, N. Faucon-Biguet, B. Grima, P. Horellou, J. F. Julien, P. Kahn, A. Lamouroux, et al. 1987. A molecular genetic approach to the study of catecholamines. Biochem. Soc. Trans. 15: 126-128.
37. 37. Marsden, C. D., and J. D. Parkes. 1976. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1: 292-296.
38. 38. Matsuse, T., Y. Namba, K. Ikeda, S. Inoue, T. Hosoi, Y. Ouchi, Y. Fukuchi, and H. Orimo. 1994. Immunohistochemical and in situ hybridisation detection of adenovirus early region 1A (E1A) gene in the microglia of human brain tissue. J. Clin. Pathol. 47: 275-277.
39. 39. Nilaver, G., L. L. Muldoon, R. A. Kroll, M. A. Pagel, X. O. Breakefield, B. L. Davidson, and E. A. Neuwelt. 1995. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc. Natl. Acad. Sci. USA 92: 9829-9833.
40. 40. Onifer, S. M., S. R. Whittemore, and V. R. Holets. 1993. Variable morphological differentiation of a raphe-derived neuronal cell line following transplantation into the adult rat CNS. Exp. Neurol. 122: 130-142.
41. 41. Palella, T. D., Y. Hidaka, L. J. Silverman, M. Levine, J. Glorioso, and W. N. Kelley. 1989. Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus. Gene 80: 137-144.
42. 42. Perez-Cruet, M. J., T. W. Trask, S. H. Chen, J. C. Goodman, S. L. Woo, R. G. Grossman, and H. D. Shine. 1994. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res. 39: 506-511.
43. 43. Perlow, M. J., W. J. Freed, B. J. Hoffer, Å. Seiger, L. Olson, and R. J. Wyatt. 1979. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204: 643-646.
44. 44. Renfranz, P. J., M. G. Cunningham, and R. D. G. McKay. 1991. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66: 713-729.
45. 45. Revah, F., P. Horellou, E. Vigne, G. Le Gal la Salle, J.-J. Robert, M. Perricaudet, and J. Mallet. 1996. Gene therapy of degenerative and genetic disorders of the central and peripheral nervous system using adenoviral vectors. In P. Lowenstein and L. Enquist, Eds., Gene Transfer into Neurones - Towards Gene Therapy of Neurological Disorders, pp. 81-92. Wiley New York.
46. 46. Ridoux, V., J. J. Robert, X. Zhang, M. Perricaudet, J. Mallet, and G. Le Gal La Salle. 1994. The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. NeuroReport 5: 801-804.
47. 47. Ridoux, V., J. J. Robert, X. Zhang, M. Perricaudet, J. Mallet, and G. Le Gal La Salle. 1994. Adenoviral vectors as functional retrograde neuronal tracers. Brain Res. 648: 171-175.
48. 48. Rubin, B. A., and L. B. Rorke. 1988. Adenovirus vaccines. In Plotkin and Mortimer, Eds., Vaccines, pp. 492-512. Saunders, Philadelphia.
49. 49. Sabaté, O., P. Horellou, E. Vigne, P. Colin, M. Perricaudet, M. H. Buc-Caron, and J. Mallet. 1995. Transplantation to the rat brain of human neural progenitors which were genetically modified using adenoviruses. Nature Genet. 9: 256-260.
50. 50. Shewach, D. S., L. K. Zerbe, T. L. Hughes, B. J. Roessler, X. O. Breakefield, and B. L. Davidson. 1994. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther. 1: 107-112.
51. 51. Snyder, E. Y., D. L. Deitcher, C. Walsh, S. Arnold-Aldea, E. A. Hartwieg, and C. L. Cepko. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68: 33-51.
52. 52. Stratford-Perricaudet, L. D., M. Levrero, J. F. Chase, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum. Gen. Ther. 1: 241-256.
53. 53. Tishon, A., M. Eddleston, J. C. de la Torre, and M. B. Oldstone. 1993. Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Virology 197: 463.
54. 54. Takayama, H., J. Ray, H. K. Raymon, A. Baird, J. Hogg, L. J. Fisher, and F. H. Gage. 1995. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of parkinson's disease. Nat. Med. 1: 53-58.
55. 55. Townsen, J. J., and J. R. Baringer. 1979. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Lab. Invest. 40: 178.
56. 56. Uchida, K., A. Ishii, N. Kaneda, S. Toya, T. Nagatsu, and S. Kohsaka. 1990. Tetrahydrobiopterin-dependent production of L-DOPA in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: Future use for intracerebral grafting. Neurosci. Lett. 109: 282-286.
57. 57. Ungerstedt, U., and G. W. Arbuthnott. 1970. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493.
58. 58. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Gregoire, P. Briand, J. C. Kaplan, A. Kahn, and M. Perricaudet. 1993. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5: 130-134.
59. 59. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127: 257-264.
60. 60. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
61. 61. Wolfe, J. D., S. L. Deshmane, and N. W. Fraser. 1992. Herpes virus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nature Genet. 1: 379-384.
62. 62. Wolff, J. A., L. J. Fisher, L. Xu, H. A. Jinnah, P. J. Langlais, P. M. Iuvone, K. L. O'Malley M. B. Rosenberg, S. Shimohama, T. Friedmann, and F. H. Gage. 1989. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 86: 9011-9014.
63. 63. Yang, Y., F. A. Nunes, K. Berensci, E. Gönczöl, J. F. Englehardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7: 362-369.
64. 64. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gönczöl, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.
65. 65. Yang, Y., Z. Xiang, H. C. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92: 7257-7261.
66. 66. Yeh, P., J. F. Dedieu, C. Orsini, E. Vigne, P. Denefle, and M. Perricaudet. 1996. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70: 559-565.
67. 67. Yoshimoto, Y., Q. Lin, T. J. Collier, D. M. Frim, X. O. Breakefield, and M. C. Bohn. 1995. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691: 25-36.
68. 68. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207-216.